Anteris Technologies Global Corp.
AVR
Rank in Stocks
#11671
Anteris Technologies Global Corp. is a structural heart innovator dedicated to... Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Share Price
$5.32
Last synced: 2026-11-17
Market Cap
$518.49M
Change (1 day)
-6.67%
Change (1 year)
57.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Anteris Technologies Global Corp. (AVR)
Category
Healthcare
EPS for Anteris Technologies Global Corp. (AVR)
EPS as of September 2026 TTM: $-2.10
According to Anteris Technologies Global Corp.'s latest financial reports, its current EPS (TTM) is $-2.10. At the end of 2025 the company had an EPS of $-2.55, an increase over its 2024 EPS of $-3.77.
EPS history for Anteris Technologies Global Corp. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.10 | -17.65% |
| 2025 | $-2.55 | -32.36% |
| 2024 | $-3.77 | 194.53% |
| 2023 | $-1.28 | 50.59% |
| 2022 | $-0.85 | 77.08% |
| 2021 | $-0.48 | 45.45% |
| 2020 | $-0.33 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -228.57% |
US
|
|
| $4.09 | -294.76% |
IE
|
|
| $9.45 | -550.00% |
US
|
|
| $2.37 | -212.86% |
US
|
|
| $1.77 | -184.29% |
US
|
Questions about Anteris Technologies Global Corp.'s earnings per share (EPS)
What is Anteris Technologies Global Corp.'s earnings per share (EPS)?
Anteris Technologies Global Corp.'s earnings per share (EPS) over the last twelve months is $-2.10, as of Sep 2026.
What was Anteris Technologies Global Corp.'s earnings per share (EPS) in 2025?
In 2025, Anteris Technologies Global Corp.'s earnings per share (EPS) was $-2.55, compared with $-3.77 in 2024.
How has Anteris Technologies Global Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Anteris Technologies Global Corp.'s earnings per share (EPS) was highest in 2020 ($-0.33) and lowest in 2024 ($-3.77).
How does Anteris Technologies Global Corp.'s earnings per share (EPS) compare with similar companies?
Anteris Technologies Global Corp.'s earnings per share (EPS) ($-2.10) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.